Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
591 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00121836 | A Study of Xeloda (Capecitabine) in Women With HER2-Negative Metastatic Breast Cancer | completed | Phase 4 | 109 | Hoffmann-La RocheINDUSTRY | 1 | Apr 27, 2011 | clinicaltrials |
| NCT00629993 | Dissemination of Cervical Cancer Screening to Primary Care Physicians in Underserved Communities | terminated | Phase 4 | 282 | Columbia UniversityOTHER | 1 | Mar 1, 2011 | clinicaltrials |
| NCT00441311 |
| Dissemination of Colorectal Cancer Screening to Primary Care Physicians |
| completed |
| Phase 4 |
| 264 |
| Columbia UniversityOTHER |
| 1 |
| Feb 1, 2011 |
| clinicaltrials |
| NCT00082277 | Anastrozole Biphosphonate Study in Postmenopausal Women With Hormone-Receptor-Positive Early Breast Cancer(SABRE) | completed | Phase 4 | 237 | AstraZenecaINDUSTRY | 8 | Jan 26, 2011 | clinicaltrials |
| NCT00106392 | A Safety and Efficacy Study of Prograf in the Prevention of Erectile Dysfunction After Radical Prostatectomy | completed | Phase 4 | 131 | Astellas Pharma IncINDUSTRY | 1 | Nov 23, 2010 | clinicaltrials |
| NCT00116649 | Open-Label Safety Study to Evaluate Imiquimod Cream, 5% for Large Areas of Actinic Keratosis | completed | Phase 4 | 551 | Graceway Pharmaceuticals, LLCINDUSTRY | 1 | Jul 20, 2010 | clinicaltrials |
| NCT00493987 | The Role of 5-alpha Reductase in Mediating Testosterone Actions(5aR) | completed | Phase 4 | 184 | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)NIH | 1 | May 13, 2010 | clinicaltrials |
| NCT01030263 | A Trial Comparing Yield of Confocal Endomicroscopy Guided Biopsies | terminated | Phase 4 | 18 | Mayo ClinicOTHER | 1 | Mar 25, 2010 | clinicaltrials |
| NCT00422708 | Local Anesthesia for Prostate Biopsy | completed | Phase 4 | 243 | Mayo ClinicOTHER | 1 | Jan 20, 2010 | clinicaltrials |
| NCT00035997 | Open-label Trial on the Effect of I.V. Zoledronic Acid 4 mg on Bone Density in Hormone Sensitive Prostate Cancer Patients With Bone Metastasis | completed | Phase 4 | 261 | Novartis PharmaceuticalsINDUSTRY | 1 | Nov 23, 2009 | clinicaltrials |
| NCT00081926 | Gleevec Trial in Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia | completed | Phase 4 | 112 | Novartis PharmaceuticalsINDUSTRY | 1 | Nov 23, 2009 | clinicaltrials |
| NCT00099541 | Non-small Cell Lung Cancer Registry | completed | Phase 4 | 300 | Novartis PharmaceuticalsINDUSTRY | 1 | Nov 23, 2009 | clinicaltrials |
| NCT00050635 | STOP Trial - Sandostatin LAR Depot Trial for the Optimum Prevention of Chemotherapy Induced Diarrhea | completed | Phase 4 | 150 | Novartis PharmaceuticalsINDUSTRY | 1 | Nov 19, 2009 | clinicaltrials |
| NCT00090038 | Effect of Rituximab on Immunological Recall Response to Specific Antigens in the Treatment of Non-Hodgkin's Lymphoma | completed | Phase 4 | 168 | BiogenINDUSTRY | 11 | Oct 20, 2009 | clinicaltrials |
| NCT00484614 | Study the Role of Positron Emission Mammography in Pre-surgical Planning for Breast Cancer | unknown | Phase 4 | 472 | Naviscan PET SystemsINDUSTRY | 1 | Sep 3, 2009 | clinicaltrials |
| NCT00134589 | CHOICE: Communicating Health Options Through Information and Cancer Education | completed | Phase 4 | 450 | Centers for Disease Control and PreventionFED | 1 | Aug 4, 2009 | clinicaltrials |
| NCT00352261 | An Open Label pH Comparison of Esomeprazole and Lansoprazole in Barrett's Esophagus Patients | completed | Phase 4 | 80 | AstraZenecaINDUSTRY | 1 | Mar 26, 2009 | clinicaltrials |
| NCT00129870 | CONCEPT: Comparison of Oxaliplatin vs Conventional Methods With Calcium/Magnesium in First-Line Metastatic Colorectal Cancer | terminated | Phase 4 | 180 | SanofiINDUSTRY | 1 | Feb 13, 2009 | clinicaltrials |
| NCT00628784 | Endoesophageal Cryotherapy For Ablating Barrett's Esophagus and Early Stage Esophageal Cancer | unknown | Phase 4 | 100 | Walter Reed Army Medical CenterFED | 1 | Jul 24, 2008 | clinicaltrials |
| NCT00377273 | An Open-Label 18-Month Safety Study of Fluorouracil Cream 0.5% for the Treatment of Actinic Keratoses | completed | Phase 4 | 250 | SanofiINDUSTRY | 1 | Apr 10, 2008 | clinicaltrials |
| NCT00651911 | Fasturtec TLS Treatment / Prophylysis | completed | Phase 4 | 45 | SanofiINDUSTRY | 1 | Apr 3, 2008 | clinicaltrials |
| NCT00050999 | Study of ONTAK (Denileukin Diftitox) in Cutaneous T-Cell Lymphoma (CTCL) Patients | completed | Phase 4 | 195 | Eisai Inc.INDUSTRY | 10 | Mar 5, 2008 | clinicaltrials |
| NCT00051012 | Study of ONTAK (Denileukin Diftitox) in Previously Treated Cutaneous T-Cell Lymphoma Patients | completed | Phase 4 | 86 | Eisai Inc.INDUSTRY | 9 | Mar 5, 2008 | clinicaltrials |
| NCT00211198 | Study of ONTAK® to Treat Cutaneous T-Cell Lymphoma (CTCL) | completed | Phase 4 | 60 | Eisai Inc.INDUSTRY | 1 | Mar 5, 2008 | clinicaltrials |
| NCT00001730 | Study of Radioiodine (131-I) Uptake Following Administration of Thyrogen and Hypothyroid States During Thyroid Hormone Withdrawal. | completed | Phase 4 | 20 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00075166 | Surgery Versus Radiosurgery to Treat Metastatic Brain Tumors | completed | Phase 4 | 130 | National Institute of Neurological Disorders and Stroke (NINDS)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00140036 | Pharmacogenomics Blood Sampling Protocol For Irinotecan/Fluorouracil/Leucovorin(CPT-11/FU/LV). | completed | Phase 4 | 137 | PfizerINDUSTRY | 2 | Mar 3, 2008 | clinicaltrials |
| NCT00380965 | Evaluation of the Efficacy of Cesamet™ for the Treatment of Pain in Patients With Chemotherapy-Induced Neuropathy | completed | Phase 4 | 23 | NEMA Research, Inc.INDUSTRY | 1 | Feb 15, 2008 | clinicaltrials |
| NCT00257114 | Evaluation of VELCADE Given as Retreatment to Multiple Myeloma Patients for Efficacy, Safety and Tolerability | completed | Phase 4 | — | Millennium Pharmaceuticals, Inc.INDUSTRY | 1 | Feb 11, 2008 | clinicaltrials |
| NCT00067730 | A Safety Evaluation of Drotrecogin Alfa (Activated) in Patients With Blood Cancer, Severe Infection Related to Bone Marrow Transplantation | completed | Phase 4 | 7 | Eli Lilly and CompanyINDUSTRY | 1 | Dec 7, 2007 | clinicaltrials |
| NCT00216424 | Capecitabine (Xeloda) and Radiation for Patients With Rectosigmoid Carcinoma | terminated | Phase 4 | 40 | James A. Haley Veterans Administration HospitalFED | 1 | Nov 12, 2007 | clinicaltrials |
| NCT00540930 | Intravitreal Ranibizumab for the Prevention of Radiation Maculopathy Following Plaque Radiotherapy | unknown | Phase 4 | 400 | Shields, Shields and AssociatesOTHER | 1 | Oct 8, 2007 | clinicaltrials |
| NCT00491946 | A Pharmacokinetic Study of Actinomycin-D and Vincristine in Children With Cancer | unknown | Phase 4 | 24 | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)NIH | 1 | Jun 26, 2007 | clinicaltrials |
| NCT00190697 | A Study of LY353381 (Arzoxifene) for Patients Who Benefitted From This Drug in Other Oncology Trials and Wished to Continue Treatment | completed | Phase 4 | 70 | Eli Lilly and CompanyINDUSTRY | 1 | May 25, 2007 | clinicaltrials |
| NCT00234195 | Wellbutrin XL, Major Depressive Disorder and Breast Cancer | completed | Phase 4 | 25 | Thomas Jefferson UniversityOTHER | 1 | Apr 17, 2007 | clinicaltrials |
| NCT00029523 | DepoCyt Therapy in Patients With Neoplastic Meningitis From Lymphoma or a Solid Tumor | completed | Phase 4 | 100 | Pacira Pharmaceuticals, IncINDUSTRY | 2 | Feb 28, 2007 | clinicaltrials |
| NCT00115154 | Study to Assess the Safety and Efficacy of Imiquimod 5% Cream for the Treatment of Actinic Keratosis on the Arms and Hands | completed | Phase 4 | 270 | Graceway Pharmaceuticals, LLCINDUSTRY | 1 | Feb 19, 2007 | clinicaltrials |
| NCT00103623 | The Plenaxis® Experience Study | suspended | Phase 4 | 2,000 | PRAECIS Pharmaceuticals Inc.INDUSTRY | 1 | Sep 19, 2006 | clinicaltrials |
| NCT00158041 | Subcutaneous Amifostine Safety Study | completed | Phase 4 | 452 | Mt. Sinai Medical Center, MiamiOTHER | 1 | Sep 12, 2005 | clinicaltrials |
| NCT00131313 | Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia. | unknown | Phase 4 | 180 | East Valley Hematology and Oncology Medical GroupOTHER | 1 | Aug 18, 2005 | clinicaltrials |
Data updated 22 days agoSource updated unknownsource: clinicaltrials